Drilldown: Medicines
Appearance
Medicines > routes:
Oral
& onset
:
30–60 min
or
LDL lowering at 2 weeks, max by 4 weeks; cardiovascular benefit months to years 
& onset
:
30–60 min
or
LDL lowering at 2 weeks, max by 4 weeks; cardiovascular benefit months to years 
Use the filters below to narrow your results.
None (1) ·
Norepinephrine–dopamine reuptake inhibition (DAT, NET), d-threo enantiomer of methylphenidate (1) ·
Selective inhibitor of phosphodiesterase type 5 (PDE5), preventing cGMP breakdown in vascular smooth muscle. In the corpus cavernosum, potentiates the NO/cGMP cascade triggered by sexual stimulation. (1)
Category B (1) ·
Category C (1) ·
Previously Category X; FDA removed the blanket statin contraindication in pregnancy in 2021. Use individualized; lactation generally avoided.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 3 results in range #1 to #3.

